Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma

Clinical trial NCT03568929 · COMPLETED

Trial details

NCT number: NCT03568929
Sponsor: Gilead Sciences
Status: COMPLETED
Study type: OBSERVATIONAL

Follicular Non-Hodgkin's Lymphoma Refractory

Start date: 2018-05-25
Primary completion: 2021-10-29
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.